Skip to Main Content

Paper Details

Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.
Nat Commun
149
2017
IGF, IGF signalling genes, IGF1 receptor, IGF1R, Osteosarcoma, childhood, childhood and adult tumours, children, chromothripsis, genomic regions, insulin-like growth factor, insulin-like growth factor (IGF) signalling genes, osteosarcoma, osteosarcomas, patient, primary malignancy of bone
Author NameAffiliation
Patrick S TarpeyWellcome Trust Sanger Institute
Ludmil B AlexandrovLos Alamos National Laboratory
Ludmil B AlexandrovLos Alamos National Laboratory
David C WedgeOxford Big Data Institute and Oxford Centre for Cancer Gene Research
Inigo MartincorenaWellcome Trust Sanger Institute
Susanna L CookeWellcome Trust Sanger Institute
Mark MaddisonWellcome Trust Sanger Institute
Adam ButlerWellcome Trust Sanger Institute
Jon TeagueWellcome Trust Sanger Institute
Ultan McDermottWellcome Trust Sanger Institute
Phillip A FutrealWellcome Trust Sanger Institute
Phillip A FutrealMD Anderson Cancer Center, University of Texas
Daniel BaumhoerInstitute of Pathology, University Hospital Basel, University of Basel
Ola MyklebostOslo University Hospital
Ola MyklebostUniversity of Bergen
Fernanda AmaryRoyal National Orthopaedic Hospital NHS Trust
Fernanda AmaryRoyal National Orthopaedic Hospital NHS Trust
Roberto TiraboscoRoyal National Orthopaedic Hospital NHS Trust
Roberto TiraboscoRoyal National Orthopaedic Hospital NHS Trust
Peter Van LooThe Francis Crick Institute
Peter Van LooUniversity of Leuven
Michael R StrattonWellcome Trust Sanger Institute
Adrienne M FlanaganRoyal National Orthopaedic Hospital NHS Trust
Adrienne M FlanaganUniversity College London Cancer Institute
Adrienne M FlanaganRoyal National Orthopaedic Hospital NHS Trust
Adrienne M FlanaganUniversity College London Cancer Institute
Peter J CampbellWellcome Trust Sanger Institute
Peter J CampbellUniversity of Cambridge
  • 1 - 28

Datasets

Release 1.2